Group I Type of group

EFFICACY AND SAFETY OF MOXIFLOXACIN 400 MG 1 TIME A DAY FOR 5 DAYS COMPARED WITH CLARITOMYCIN 250 MG 2 TIMES A DAY FOR 10 DAYS IN THE TREATMENT OF PHARINGO AMIGDALITIS IN ADULT PATIENTS CLINICAL STUDY PHASE III PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED IN PARALLEL GROUPS, MULTICENTRIC AND MULTINATIONAL

A Phase III Study Comparing the Antiviral Efficacy and Safety of BMS-232632 with Efavirenz; Each in Combination with Fixed Dose Zidovudine-Lamivudine

Multicenter, Randomized, Double Blind, Parallel Group, Controlled with Placebo and Active Study, Carried Out Under Internal Blind Conditions whose Purpose is to Determine the Incidence of Gastroduodenal Ulcers in Patients Suffering from Osteoarthritis after 12 Weeks of Placebo Treatment, Low Dose of Aspirin, MK-0966 plus Low Dosage of Aspirin or Ibuprofen.

Parallel Two-Arm, Triple-Blind, Randomized Study, whose purpose is to evaluate the efficacy, tolerability and safety of the Dosage of 50 mg of Losartan titled at 50 mg of Losartan / 12.5 mg of Hydrochlorothiazide, titrated to 100 mg of Losartan / 25 mg of Hydrochlorothiazide versus the dose of 5 mg of Amlodipine titrated to 10 mg of Amlodipine, titrated to 10 mg of Amlodipine plus 25 mg of Hydrochlorothiazide in patients suffering from Isolated Systolic Hypertension.

Randomized, Double Blind, Parallel Group, Controlled with Placebo Study performed Under Internal Blind Conditions whose Purpose is to Examine the Safety, Tolerability and Efficacy of MK-0869 for the Prevention of Nausea and Vomiting Induced by Chemotherapy Associated with Administration of High doses of Cisplatin.

Prospective, randomized, non-blind, comparative with parallel groups, multicenter and multinational phase IH clinical study of the efficacy and safety of moxifloxacin 400 mg od sequential therapy versus amoxicillin/clavulanate 1 g IV tid followed by amoxicillin/clavulanate 625 mg PO tid for the treatment of complicated skin and skin structure infections during a 21-day period (Study 10279)

THE EFFECT OF NEXIUM (ESOMEPRAZOL) MORE CLARITHROMYCIN AND AMOXICILLIN FOR A WEEK COMPARED WITH CONVENTIONAL THERAPY OF LOSEC (OMEPRAZOL) FOR 1 WEEK WITH FOLLOWING MONOTHERAPY FOR THREE WEEKS FOR THE TREATMENT OF THE ERADICATION OF HELICOBACTER PYLORI AND SCATTERING OF THE DUODENAL ULCER , BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTICENTER, MULTINATIONAL EMSDO STUDY

A RANDOMIZED OPEN-LABEL STUDY OF THE ANTIVIRAL EFFICACY AND SAFETY OF ATAZANAVIR VERSUS LOPINAVIRHHTONAVIR (LPV/RTV), EACH IN COMBINATION WITH TWO NUCLEOSIDES IN SUBJECTS WHO HAVE EXPERIENCED VIROLOGIC FAILURE WITH PRIOR PROTEASE INHIBITOR-CONTAINING HAART REGIIVIEN(S)

An Open-Label Study to Demonstrate Bacteriologic Efficacy Augmentin ES in the Treatment of AOM Due to S. pneiimoniae: Revised PRSP Report

MULTINATIONAL, MULTICENTRIC, RANDOMIZED, OPEN STUDY TO ESTABLISH THE OPTIMUM METHOD FOR INITIATING AND MAINTAINING LANTUS THERAPY (INSULIN GLARGINE) BASED ON THE COMPARISON OF TWO TREATMENT ALGORITHMS TO DETERMINE THE OPTIMUM METABOLIC CONTROL, SECURITY AND SATISFACTION IN SUBJECTS WITH DIABETES MELLITUS TYPE 2

MULTICENTER, OBSERVATIONAL, LONG-TERM STUDY ON THE IMPACT OF THE THERAPEUTIC DECISION TAKEN IN PATIENTS RECEIVING A TRANSPLANT OF SOLID ORGAN, WHO WILL RECEIVE SANDIMMUN NEORAL IN CIRCUMSTANCES OF NORMAL CLINICAL PRACTICE.

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy